BioLife Historical Cash Flow
| BLFS Stock | USD 27.47 0.31 1.14% |
Analysis of BioLife Solutions cash flow over time is an excellent tool to project BioLife Solutions future capital expenditures as well as to predict the amount of cash needed to cover cost of sales, R&D expenses or production expansions. Investors should almost always look for trends in cash flow indicators such as Change In Cash of 16.8 M or Change In Working Capital of 1.5 M as it is a great indicator of BioLife Solutions ability to facilitate future growth, repay debt on time or pay out dividends.
Financial Statement Analysis is much more than just reviewing and examining BioLife Solutions latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether BioLife Solutions is a good buy for the upcoming year.
BioLife |
About BioLife Cash Flow Analysis
The Cash Flow Statement is a financial statement that shows how changes in BioLife balance sheet and income statement accounts affect cash and cash equivalents. It breaks the analysis down to operating, investing, and financing activities. One of the most critical aspects of the cash flow statement is liquidity, which is the degree to which BioLife's non-liquid assets can be easily converted into cash.
BioLife Solutions Cash Flow Chart
Add Fundamental
Free Cash Flow
The amount of cash a company generates after accounting for cash outflows to support operations and maintain its capital assets.Begin Period Cash Flow
The amount of cash a company has at the beginning of a financial reporting period. It serves as the starting point for calculating the period's cash flow from operations, investing, and financing activities.Capital Expenditures
Capital Expenditures are funds used by BioLife Solutions to acquire physical assets such as property, industrial buildings or equipment. This type of outlay is used by management to increase the scope of BioLife Solutions operations. These expenditures can include everything from repairing an office equipment, building a brand new facility, or writing new software.Stock Based Compensation
Compensation provided to employees in the form of equity or options to purchase company stock. This type of compensation is used to align the interests of employees and shareholders.Investments
Securities or assets acquired for generating income or appreciating in value, not used in daily operations.Most accounts from BioLife Solutions' cash flow statement are interrelated and interconnected. However, analyzing cash flow statement accounts one by one will only give a small insight into BioLife Solutions current financial condition. On the other hand, looking into the entire matrix of cash flow statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in BioLife Solutions. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in census. For more information on how to buy BioLife Stock please use our How to Invest in BioLife Solutions guide.At this time, BioLife Solutions' End Period Cash Flow is comparatively stable compared to the past year. Change To Account Receivables is likely to gain to about 16.1 M in 2024, despite the fact that Total Cash From Operating Activities is likely to grow to (11.9 M).
BioLife Solutions cash flow statement Correlations
Click cells to compare fundamentals
BioLife Solutions Account Relationship Matchups
High Positive Relationship
High Negative Relationship
BioLife Solutions cash flow statement Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Sale Purchase Of Stock | 3.9M | (4.3M) | 1.8M | 101.6M | 116.9M | 122.7M | |
| Change In Cash | (24.2M) | 84.0M | (20.6M) | (50.4M) | 16.0M | 16.8M | |
| Free Cash Flow | 538K | 1.9M | (13.2M) | (18.9M) | (18.9M) | (17.9M) | |
| Change In Working Capital | (4.5M) | (1.8M) | (3.5M) | (14.9M) | 1.5M | 1.5M | |
| Begin Period Cash Flow | 30.7M | 6.4M | 90.5M | 69.9M | 19.5M | 20.4M | |
| Other Cashflows From Financing Activities | (159K) | 973K | 116K | (1.5M) | 845K | 1.3M | |
| Depreciation | 1.8M | 5.1M | 12.9M | 16.5M | 12.3M | 12.9M | |
| Other Non Cash Items | 4.0M | (2.1M) | (364K) | 109.7M | 8.6M | 9.0M | |
| Capital Expenditures | 675K | 4.6M | 8.4M | 10.4M | 6.4M | 6.7M | |
| Total Cash From Operating Activities | 1.2M | 6.5M | (4.8M) | (8.5M) | (12.5M) | (11.9M) | |
| Net Income | (1.7M) | 2.7M | (7.6M) | (139.8M) | (66.4M) | (63.1M) | |
| Total Cash From Financing Activities | 1.6M | 101.2M | (2.8M) | 16.3M | 10.6M | 7.0M | |
| End Period Cash Flow | 6.4M | 90.5M | 69.9M | 19.5M | 35.4M | 37.2M | |
| Change To Inventory | (3.8M) | (629K) | 114K | (6.6M) | (8.6M) | (8.1M) | |
| Change To Account Receivables | (290K) | (1.8M) | (10.1M) | (10.8M) | 15.4M | 16.1M | |
| Change To Liabilities | 466.5K | 486K | 441K | (171K) | 2.0M | 0.0 | |
| Total Cashflows From Investing Activities | (27.0M) | (23.7M) | (12.6M) | (58.1M) | (52.3M) | (49.7M) | |
| Other Cashflows From Investing Activities | 1.3M | (23.7M) | (12.6M) | (58.1M) | (52.3M) | (49.7M) | |
| Stock Based Compensation | 3.0M | 6.0M | 14.0M | 25.3M | 31.7M | 18.7M | |
| Change Receivables | 172.3K | (2.0M) | (290K) | (1.8M) | (1.6M) | (1.5M) | |
| Net Borrowings | 979.8K | (56K) | 984K | (2.9M) | (2.6M) | (2.5M) | |
| Cash And Cash Equivalents Changes | 5.3M | 24.0M | (24.2M) | 84.0M | 96.6M | 101.4M | |
| Cash Flows Other Operating | (113.0K) | (120K) | (10.3M) | 1.1M | 1.0M | 1.1M | |
| Change To Netincome | 15.0M | (1.2M) | (9.0M) | 114.8M | 132.0M | 138.6M | |
| Investments | 1M | (23.7M) | (12.6M) | (58.1M) | (1.0M) | (1.1M) | |
| Change To Operating Activities | (1.2M) | 805K | 4.5M | 2.0M | 2.3M | 2.4M |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for BioLife Stock Analysis
When running BioLife Solutions' price analysis, check to measure BioLife Solutions' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BioLife Solutions is operating at the current time. Most of BioLife Solutions' value examination focuses on studying past and present price action to predict the probability of BioLife Solutions' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BioLife Solutions' price. Additionally, you may evaluate how the addition of BioLife Solutions to your portfolios can decrease your overall portfolio volatility.